Our mission is to improve the prognosis and quality of life of patients with cancer. We aim to achieve this by initiating and conducting groundbreaking research focused on developing new methods of treatment.
The two main treatment modalities under investigation are immunotherapy and targeted therapy. The ambition is to validate and, where possible, translate the results obtained from fundamental and clinically oriented research on new treatment strategies through preclinical and early clinical studies, in order to bring these findings to societal benefit.
Research groups
- Group of Elisa Giovannetti
- Group of Arjan Griffioen
- Group of Connie Jimenez
- Group of Victor van Beusechem
- Group of Tanja de Gruijl
- Group of Hanneke van Laarhoven
- Group of Sarah Derks
Contact
Amsterdam UMC, Locatie VUmc: RDC ZH 2J 012